Medical Advocates
ARV/HAART
  Salvage Therapy

 New and Noteworthy
 Journal Papers, Abstracts, and Commentaries
Conference Reports, Abstracts, and Posters  


 



 
HAART Main Page Main New/Newsworthy Home Page      
Last Update:  July 06, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
    
June 2008
 
Journal Papers, Abstracts, and Commentaries
    
 
New treatment options for HIV salvage patients: An overview of second generation PIs, NNRTIs, integrase inhibitors and
CCR5 antagonists.
 Hughes A, Barber T, Nelson M
 J  Infect. 2008 Jun 13
 Abstract
 
A WEEK IN REVIEW FEATURED REPORT
Early Changes in T-Cell Activation Predict Antiretroviral Success in Salvage Therapy of HIV
Infection.
Shepard BD, Loutfy MR, Raboud J, et al 
J Acquir Immune Defic Syndr. 2008 Mar 20
 Abstract
 
Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults.
Temesgen Z, Cainelli F, Poeschla EM, et al 
Lancet Infect Dis. 2006 Aug;6(8):496-507
 Abstract
 
Virological and pharmacological factors associated with virological response to salvage therapy
after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART
ANRS 097).
Delaugerre C, Peytavin G, Dominguez S, et al
J Med Virol. 2005 Sep 19;77(3):345-350
 Abstract
 
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or
phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-
controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study.
Torti C, Quiros-Roldan E, Regazzi M, et al
 Clin Infect Dis. 2005 Jun 15;40(12):1828-36
 Abstract
 
Deep Salvage With Amprenavir and Lopinavir/Ritonavir: Correlation of Pharmacokinetics
and Drug Resistance With Pharmacodynamics.
De Luca A, Baldini F, Cingolani A
J Acquir Immune Defic Syndr. 2004 Apr 20;35(4):359-366.
Abstract
 
HIV protease mutations associated with amprenavir resistance during salvage therapy:
importance of I54M.
Murphy MD, Marousek GI, Chou S.
J Clin Virol. 2004 May;30(1):62-7.
 Abstract

Therapy has failed: rationale and design of the OPTIMA Trial.
Kyriakides TC, Babiker A, Singer J, et al.
Control Clin Trials. 2003 Aug;24(4):481-500.
 Abstract

A randomized trial to investigate the recycling of stavudine and didanosine with and without
hydroxyurea in salvage therapy (RESTART).
Stebbing J, Nelson M, Orkin C,
J Antimicrob Chemother. 2004 Mar;53(3):501-5.
 
Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human
Immunodeficiency Virus Type 1-Infected Patients: The MaxCmin1 Trial.
 Dragsted UB, Gerstoft J, Pedersen C, et al.  
J Infect Dis. 2003 Sep 1;188(5):635-42.
 Abstract
 
  Virological and immunological effects of salvage therapy following treatment interruption  and a
shift in HIV-1 resistance genotype.
Izopet J, Souyris C, Sandres-Saune K, et al
 Med Virol 2002 Nov;68(3):305-10
 Abstract		  
  Salvage antiretroviral therapy in HIV infection.
 Walmsley SL, Loutfy MR.
Expert Opin Pharmacother 2002  Feb;3(2):81-90
 Abstract
 		  
 

Impact of HIV Type 1 Drug Resistance Mutations and Phenotypic Resistance Profile on Virologic
Response to Salvage Therapy.
Ross L, Liao Q, Gao H, Pham S, et al.
AIDS Res Hum Retroviruses 2001 Oct;17(15):1379-85
Abstract

The use of efavirenz as a part of late rescue antiretroviral treatment.
Manfredi R, Rizzo E, Calza L, Chiodo F. 
HIV Clin Trials 2001 Sep-Oct;2(5):413-20
 Abstract
 
Randomized salvage therapy with saquinavir-ritonavir versus saquinavir-nelfinavir for highly
protease inhibitor-experienced HIV-infected patients.
Chavanet P, Piroth L, Grappin M, et al.
HIV Clin Trials 2001 Sep-Oct;2(5):408-12
 Abstract
 
Adding two new drug classes improves outcome in salvage therapy.
Havlir D.
AIDS Clin Care 2001 Oct;13(10):99
Abstract
 
Nelfinavir plus nevirapine plus two nrtis as salvage therapy for hiv-infected patients receiving
long-term antiretroviral treatment.
Perez-Molina JA, Perez Nr R, Miralles P, et al.
HIV Clin Trials 2001 Jan-Feb;2(1):1-5
 Abstract
 

HAART Main Page Main New/Newsworthy Home Page

Salvage Therapy